Multiply Labs
About
About Multiply Labs
Multiply Labs builds modular robotic clusters for advanced biomanufacturing, starting with cell therapies. Four Universal Robots arms coordinate instrument handling, liquid transfers and other process steps inside a closed manufacturing environment. The system works around customers' established GMP instruments, while a visual process builder lets scientists configure workflows and retain control of their protocols.
Its software records process parameters, material genealogy and operator actions for quality review. Customers include AstraZeneca, Legend Biotech and Kyverna Therapeutics. Founded in 2016 by Fred Parietti and Alice Melocchi, the San Francisco company established an Italian subsidiary in Turin in 2026 to develop manufacturing capacity, supply chains and regulated-production quality systems under former Ferrari manufacturing leader Enrico Antonio Racca.
Articles
Funding
- 2026-10-06 - Series B - $75M - Multiply Labs raises $75M Series B for robotic drug manufacturing
Multiply Labs completed a NantWorks-led Series B to advance robotic manufacturing of gene therapies, mRNA and other complex medicines. - source: businessinsider.com
- 2021-04-14 - Series A - $20M - Multiply Labs raises $20M Series A for robotic drug production
Multiply Labs completed a Casdin Capital-led Series A supporting automated manufacturing of individualized medicines. - source: biospace.com
Investors
- Lux Capital - Participant - VC - 2 funding events - repeat backer - first seen 2021-04-14 - latest 2026-10-06
- AstraZeneca - Participant - Unknown - 1 funding event - first seen 2026-10-06
- Casdin Capital - Lead - VC - 1 funding event - first seen 2021-04-14
- Fifty Years - Participant - Angel / Individual - 1 funding event - first seen 2021-04-14
- Founders Fund - Participant - VC - 1 funding event - first seen 2026-10-06
- Garage Capital - Participant - VC - 1 funding event - first seen 2021-04-14
- NantWorks - Lead - Unknown - 1 funding event - first seen 2026-10-06
- Pathfinder - Participant - Unknown - 1 funding event - first seen 2021-04-14
Team
- Alice Melocchi - Co-founder and Chief Scientific Officer
- Fred Parietti - Co-founder and Chief Executive Officer
Timeline
Events
- 2026-10-06 - Funding - Multiply Labs raises $75M Series B for robotic drug manufacturing
AstraZeneca, Lux Capital and Founders Fund participated in the round. The financing brings cumulative funding since the company’s 2016 founding to more than $100 million. Customers operate the machines at their own facilities and purchase cartridges and technical support.
Source - 2026-05-27 - Org Change - Multiply Labs establishes Italian manufacturing subsidiary in Turin
Enrico Antonio Racca, former Ferrari head of supply chain and manufacturing, became founding general manager and the parent company’s supply-chain and manufacturing chief. The Turin team is being built to recruit manufacturing staff, design a scalable supply chain and establish quality systems for regulated pharmaceutical environments.
Source - 2021-04-14 - Funding - Multiply Labs raises $20M Series A for robotic drug production
Lux Capital and Pathfinder, Founders Fund’s early-stage investment vehicle, joined seed investors Fifty Years and Garage Capital. Cumulative funding exceeded $25 million after the round. The financing supported cloud-controlled robotic systems for industrial-scale production.
Source